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Human Cytomegalovirus Binding to DC-SIGN
Is Required for Dendritic Cell Infection
and Target Cell trans-Infection
in most immunocompetent individuals because of an
efficient antiviral immune response. In contrast, CMV
remains a major cause of morbidity and mortality in
newborn and immunocompromised patients, namely in
organ-transplanted recipients or AIDS patients. In any
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probably allows more stable attachment of virus to cell5 De´partement de Pathologie Ve´ge´tale
surface (Boyle and Compton, 1998). Subsequent pH-INRA
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cell membrane are necessary for viral entry (ComptonFrance
et al., 1992; Milne et al., 1998). Cell proteins involved in
CMV attachment and/or fusion have not been identified
precisely, although two candidates have been pro-Summary
posed. The first one is annexin II, which interacts with
CMV gB (Pietropaolo and Compton, 1997). The secondCytomegalovirus (CMV) infection is characterized by
one is a 92.5 kDa protein binding to CMV gH (Baldwinhost immunosuppression and multiorganic involve-
et al., 2000). Fusion events are followed by penetrationment. CMV-infected dendritic cells (DC) were recently
of the capsid which is transported to the nucleus. Inshown to display reduced immune functions, but their
some permissive cells, such as retinal pigment epithelialrole in virus dissemination is not clear. In this report,
cells, CMV can also penetrate into cells by a mechanismwe demonstrated that CMV could be captured by DC
of endocytosis (Bodaghi et al., 1999).through binding on DC-SIGN and subsequently trans-
Recently, DC, which are refractory to infection by lab-mitted to permissive cells. Moreover, blocking DC-
oratory-adapted CMV strains, were shown to be permis-SIGN by specific antibodies inhibited DC infection by
sive to CMV infection and replication when infected with
primary CMV isolates and expression of DC-SIGN or
primary, clinical viral isolates (Riegler et al., 2000). The
its homolog DC-SIGNR rendered susceptible cells per- mechanism of CMV entry into DC has not been investi-
missive to CMV infection. We demonstrated that CMV gated yet. It was recently shown that DC express a lectin
envelope glycoprotein B is a viral ligand for DC-SIGN called DC-SIGN (DC-Specific ICAM-Grabbing Noninteg-
and DC-SIGNR. These results provide new insights rin). DC-SIGN, also called CD209, is a ligand for IntraCel-
into the molecular interactions contributing to cell in- lular Adhesion Molecule-2 (ICAM-2) and ICAM-3 (Geij-
fection by CMV and extend DC-SIGN implication in tenbeek et al., 2000a, 2000c) and is involved in the
virus propagation. attachment of Human Immunodeficiency Virus-1 (HIV-1)
(Geijtenbeek et al., 2000b) and Ebola (Alvarez et al.,
Introduction 2002) to DC. DC-SIGN was originally cloned from a pla-
cental cDNA library on the basis of its capacity to bind
Human Cytomegalovirus (CMV) is a double-strand DNA to the surface subunit HIV-1 Env glycoprotein 120 (HIV-1
virus belonging to the herpesviridae family and is a ubiq- gp120) (Curtis et al., 1992). DC-SIGN mediates HIV bind-
uitous pathogen in humans. CMV interaction with its ing and internalization into DC, conferring to these cells
host is characterized by a primary infection followed the ability to transmit HIV to permissive CD4 T cells
by lifelong persistence in the host organism and viral independently from HIV-1 replication (Geijtenbeek et al.,
reactivation episodes. CMV infection is asymptomatic 2000b). These findings suggest that DC-SIGN efficiently
captures HIV-1 at mucosal sites of inoculation and facili-
tates its transport to sites of infection by using the migra-6 Correspondence: julie.dechanet@umr5540.u-bordeaux2.fr
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Figure 1. DC-SIGN-Expressing Cells Bind
CMV on Their Surface
(A) Detection of DC-SIGN. Anti-DC-SIGN
1B10 mAb (bold line). Irrelevant isotypic con-
trol mAb (dotted line). Mean fluorescence in-
tensity (MFI) values are indicated.
(B) Binding of CMV AD169 strain to cells ex-
pressing or not DC-SIGN was revealed by an
anti-envelope glycoprotein B (CMV gB) mAb.
Incubation in low pH buffer (200 PFU/cell) prior
to staining abrogates detection of CMV gB.
tory ability of DC toward lymphoid organs (Banchereau Transmission of CMV Infection to Permissive Cells
Is Mediated by DC-SIGNand Steinman, 1998). A homolog of DC-SIGN, DC-
MD-DC, THP-1, or HeLa expressing DC-SIGN were incu-SIGNR, was recently identified on the surface of endo-
bated with a mutant CMV strain encoding a GFPthelial cells and shown to display the same HIV-1 binding
(ADGFP) (Borst et al., 2001), washed, and cultured withand trans-infection enhancement capacities shown by
permissive MRC5 cells. HeLa cells were selected forDC-SIGN (Bashirova et al., 2001; Pohlmann et al.,
their refractoriness to CMV infection (Einhorn et al.,2001b). The putative role of DC-SIGN or DC-SIGNR in
1982) which persists despite transduction with DC-SIGNherpesvirus attachment to DC or endothelial cells has
(our unpublished data). MD-DC (Figure 2A), DC-SIGNnever been reported.
THP-1 (Figure 2B), and DC-SIGN HeLa cells (FigureIn the present study, we analyzed the mechanisms of
2C), in contrast to parental THP-1 or HeLa cells, con-CMV attachment to DC and the role of DC-SIGN in this
veyed CMV infection as proved by the expression ofprocess. We demonstrated that CMV is able to bind DC-
GFP in MRC-5 cells. Trans-infection of MRC-5 cells wasand DC-SIGN-expressing THP-1 cells through direct in-
prevented by preincubating MD-DC, DC-SIGN THP-1,teraction of DC-SIGN with viral envelope CMV gB. This
or DC-SIGN HeLa cells either with EGTA or mannanbinding leads to two independent results: (1) the trans-
before being pulsed with CMV. Moreover, the anti-DC-mission of DC-SIGN-bound infectious viral particles to
SIGN mAb 1B10, which blocks HIV transmission (datadifferent permissive cells and (2) an enhanced infection
not shown), also inhibited efficiently the transmission ofand CMV replication in DC- and DC-SIGN-expressing
CMV from DC-SIGN cells to MRC-5 cells. We concludeTHP-1 cells.
that transmission of CMV to susceptible cells is ac-
counted for by DC-SIGN and does not require produc-
tive infection by DC-SIGN-expressing cells.Results
The capacity of DC-SIGN to enhance infectiveness of
CMV was assessed. To these purposes, MRC-5 cellsExpression of DC-SIGN at the Cell Membrane Enables
were either incubated with low titers of cell-free CMV orBinding of CMV
cocultured with MD-DC (Figure 3A) or DC-SIGN THP-1
We investigated first the capacity of CMV to bind DC-
(Figure 3B) previously pulsed with an identical amount of
SIGN. Parental and DC-SIGN THP-1 cells, or immature CMV. Coculture of MRC-5 with CMV-pulsed DC-SIGN
monocyte-derived DC (MD-DC) were incubated on ice cells leads to a substantial enhancement of MRC-5 in-
with increasing concentrations of CMV, and the pres- fections as compared to MRC-5 exposed to cell-free
ence of cell-bound virions was quantified by flow cytom- virus. The enhancement of CMV infectivity conferred by
etry using a mAb directed against the CMV gB. While DC-SIGN cells pulsed with CMV was abrogated by
parental THP-1 cells failed to bind detectable amounts specific anti-DC-SIGN mAb 1B10 (Figures 3A and 3B).
of CMV, both DC-SIGN-expressing THP-1 and MD-DC To determine if DC-SIGN-bound CMV retains infectivity
absorbed CMV virions in a dose-dependent manner (Fig- over a more prolonged period of time than free virus,
ures 1A and 1B). Prevention of CMV gB antibody-label- DC-SIGN THP-1 were pulsed with CMV, washed, and
ing by acidic washes proved the existence of cell-bound cultured at 37C for different periods before coculture
virions (Figure 1B). Abrogation of virion attachment ob- with MRC-5 cells. In parallel, cell-free virus was incu-
served following preincubation of cells with mannan, a bated for the same period of time at 37C before being
complex sugar that binds to the Carbohydrate Recogni- added to MRC-5 cells. Our findings show that CMV re-
tion Domain (CRD) of lectins, suggests that the CMV- mains infectious for 4–5 days when bound to DC-SIGN
DC-SIGN interaction is accounted by the glycosylated whereas cell-free virus retains its infectivity only for 2
days (Figure 3C).residues of CMV envelope glycoproteins.
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Figure 2. DC-SIGN-Dependent trans-Infec-
tion of CMV-Permissive Cells
(A) MD-DC, (B) DC-SIGN versus parental
THP-1 cells, or (C) parental versus DC-SIGN
HeLa cells were pretreated with EGTA (5 mM),
mannan (20, 1, 0.05 g/ml), anti-DC-SIGN
1B10 mAb (20, 1, 0.05 g/ml), or an isotypic
control (20, 1, 0.05 g/ml) prior to incubation
with ADGFP strain (1 PFU/cell). After removal
of unbound virus and competitors, ADGFP-
challenged cells were cocultured for 3 days
with MRC-5 cells. Infection of MRC-5 was
assessed by counting the number of GFP-
expressing cells by flow cytometry.
In parallel, the detection by immunostaining of early HSV-1, or VZV and thereafter cocultured with MRC-5
cells which are fully susceptible to the three virusesmarkers of CMV replication (intranuclear immediate
early and early antigens, IEA and EA, respectively) has (Figure 4D). Expression of CMV- but not HSV-1- or VZV-
EA or -IEA in MRC-5 cells is compatible with a highbeen done (Figure 4A). The findings obtained by this
alternative assay confirmed the role of DC-SIGN in the degree of specificity for the interaction of DC-SIGN with
CMV envelope glycoproteins (Figure 4C).transmission of CMV to permissive cells and validated
the trans-infection assay. Transmission of CMV from
DC-SIGN cells is not restricted to a particular permis- DC-SIGN Cytoplasmic Tail Is Critical for Enhanced
Transmission of CMVsive cell type since DC-SIGN THP-1 cells also transmit-
ted infectious virions to the U373 MG astrocytoma cell The role proposed for DC-SIGN internalization for trans-
enhancement of HIV infection was assessed for CMVline (Figure 4B).
We next aimed at determining if other members of transmission from DC-SIGN cells to susceptible cells.
To this purpose, THP-1 cells expressing mutant forms ofthe herpesviridae family have the same capacity as CMV
to interact with DC-SIGN. To this purpose, DC-SIGN DC-SIGN (Kwon et al., 2002) encoding either combined
deletion of dileucine- and tyrosine-based motifs (DC-THP-1 cells were exposed to clinical isolate of CMV,
Immunity
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CMV infection. Both DC-SIGN mutants were expressed
in THP-1 cells with similar efficiency as the wild-type
counterpart (Figure 5A). Moreover, they displayed
roughly comparable capacities to bind CMV particles
(Figure 5B). Parental and DC-SIGN-expressing (either
wt or mutated) THP-1 cells were then assessed for their
ability to transmit CMV to permissive MRC-5 cells. We
found that following incubation with ADGFP CMV at
37C, DC-SIGN 35- or DC-SIGN 20-expressing THP-1
cells showed a marked decreased capacity to transmit
CMV as compared to DC-SIGN THP-1 cells (Figure 5C).
Incubation on ice of DC-SIGN wt-expressing THP-1 cells
with CMV prevented virus transmission to MRC-5 cells
(Figure 5C). These results suggest that, similarly to HIV
infection, trans-enhancement of CMV infection by DC-
SIGN-expressing cells requires the cytoplasmic domain
of DC-SIGN.
DC-SIGN Expression Renders Low-Susceptible Cells
Sensitive to CMV Infection and Mediates the Infection
of MD-DC by Primary CMV Isolates
We next investigated whether DC-SIGN is involved in
cis in the entry of CMV into host cells. Two complementary
approaches were developed to this purpose. First, using
either HEK 293T or THP-1 cells transduced with DC-SIGN,
we evaluated their capacity to support CMV infection. It
has been previously reported that undifferentiated THP-1
are unable to support CMV IE gene expression despite
virus entry (Lashmit et al., 1998; Weinshenker et al.,
1988). We confirmed this finding and show that the HEK
293T cell line similarly appears to be poorly susceptible
to CMV infection (ADGFP virus). In sharp contrast with
these findings, both HEK 293T and THP-1 expressing
DC-SIGN were highly susceptible to CMV infection. In-
deed, more than 40% of DC-SIGN THP-1 cells were
positive for GFP after 2 hr of contact with CMV ADGFP
followed by a 2 day incubation, while no GFP expression
was found in parental cells (Figure 6A). Similarly to DC-
SIGN, the homologous DC-SIGNR lectin was capable
of rendering HEK 293T susceptible to CMV infection
(Figure 6B). Conclusive evidence about the role played
by DC-SIGN in the infectiveness of transduced cells came
from the drastic reduction of the CMV IE gene expression
levels in both DC-SIGN THP-1 and HEK 293T cells in
the presence of anti-DC-SIGN mAb (Figure 6A).
MD-DC, which show natural expression of DC-SIGN,
Figure 3. DC-SIGN Enhances CMV trans-Infection of MRC-5 Cells were used to confirm and extend the findings observed
and Retains Long-Term Infectious Virus in the first set of experiments. By opposition to THP-1
(A) MD-DC, (B) parental, or DC-SIGN THP-1 cells were incubated cells, MD-DC are known to be permissive to infection
with ADGFP in the absence or in the presence either of anti-DC-
by primary CMV isolates. Detection of IEA and EA in aSIGN 1B10 mAb or an isotypic, control mAb. Thereafter, cells were
substantial number of MD-DC when incubated withcocultured with reporter MRC-5 cells.
TB40/E proved the susceptibility of these cells to non-(C) DC-SIGN and parental THP-1 cells were incubated (4 hr) with
ADGFP (moi  1) and washed thereafter. At days 0, 2, 4, 6, and 8 adapted, clinical CMV strains. Amazingly, preincubation
after pulse, ADGFP-challenged cells were cocultured with reporter of MD-DC with the anti-DC-SIGN 1B10 mAb prevented
MRC-5 cells for 3 days. In (A), (B), and (C), MRC-5 cells were incu- their infection by CMV with roughly the same efficiency
bated with the corresponding amount of cell-free virus to monitor
as it did in DC-SIGN THP-1 cells (Figure 6C).kinetic and extent of infection. Values represent the percentage of
Full replication of CMV in DC-SIGN-expressing cellsMRC-5 cells expressing GFP.
was then assessed by quantifying the progeny of infec-
tious virions. MRC-5, MD-DC, DC-SIGN, or parental
THP-1 cells were incubated with low titers of a primary
CMV strain, washed in acidic buffer to remove noninter-SIGN 35), or the dileucine-based motif only (DC-SIGN
20), which are putative internalization motifs required nalized virus, and thereafter cultured for 14 days. The
generation of infectious CMV virions from these cellsfor DC-SIGN endocytosis, were exposed to low MOI
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Figure 4. DC-SIGN Mediates CMV Transmission to Different Permissive Cells but Does Not Allow Transmission of HSV-1 and VZV
(A and B) DC-SIGN THP-1 cells were exposed either to anti-DC-SIGN 1B10 mAb or an isotypic control mAb prior to infection with ADGFP.
ADGFP-pulsed DC-SIGN THP-1 cells were cocultured for 24 hr either with MRC-5 (A) or U373 MG cells (B). GFP- (gray bars) or CMV IEA/
EA-expressing cells (open bars) were counted to evaluate CMV infection.
(C) DC-SIGN THP-1 cells incubated with anti-DC-SIGN 1B10 mAb (open bars) or an isotypic control mAb (dashed bars) or left untreated
(gray bars) were exposed for 1 hr to TB40/E, AD169, or Towne CMV isolates, HSV-1, or VZV. After removal of unbound virus and mAb, cells
were cocultured with MRC-5 reporter cell line for 5 days.
(D) MRC-5 cells were exposed for 5 days to an identical amount of cell-free viruses as used in (C) to infect DC-SIGN THP-1 cells. IEA/EA-
expressing cells were detected by immunocytochemistry using specific antibodies for each herpesvirus.
was quantified by plaque assay titration on MRC-5 cells. Identification of CMV Glycoprotein B
as a Viral Ligand of DC-SIGNAccumulation of CMV virions was detected in culture
supernatants from MD-DC and DC-SIGN THP-1 cells Since DC-SIGN was shown to bind HIV particles through
a specific interaction between the carbohydrate recog-(Figure 6D). The amount of infectious virions released
by MD-DC- or DC-SIGN-expressing THP-1 were 10 and nition domain (CRD) of DC-SIGN and sugar moities of
HIV-1 gp120 (Mitchell et al., 2001), we searched for an16 times, respectively, more elevated than the number
of input virus used at day 0 and comparable to amounts equivalent of HIV-1 gp120 on CMV particles. The human
CMV virion is known to harbor several different envelopereleased by MRC-5 cells (Figure 6D). Preincubation of
MD-DC or DC-SIGN THP-1 with the specific anti-DC- glycoproteins. Among them, CMV gB, gH, and gM were
shown to be directly involved in two early events of theSIGN 1B10 mAb precluded detectable generation of
CMV infectious virions, thus demonstrating the involve- CMV infection: CMV attachment and fusion between
viral and cellular membranes (Compton et al., 1993; Kariment of DC-SIGN in the cis-infection of DC-SIGN-
expressing cells (Figure 6D). and Gehrz, 1992; Milne et al., 1998). The reasons for
focusing our research on CMV gB are manifold. First,Hence, these results imply that in cis cell surface ex-
pression of DC-SIGN not only potentiates the expres- CMV gB is the most abundant and the most extensively
N- and O-glycosylated envelope glycoprotein of CMVsion of CMV IE gene products but also confers to CMV
low-susceptible cells the capacity to support a full repli- (Gibson, 1983). Second, it has been demonstrated that
sequence variations in CMV gB from different strainscative cycle in the host cell. These findings suggest a
crucial biological role of DC-SIGN in the propagation of of human CMV are lower than in other CMV envelope
glycoproteins (Chou and Dennison, 1991). Third, CMVthe CMV natural infection by DC.
Immunity
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was specifically abrogated by preincubation with the
blocking anti-DC-SIGN 1B10 mAb. Further authentica-
tion of CMV gB as a CMV DC-SIGN ligand came from
a competition assay with other viral envelope glycopro-
teins. In this assay, we preincubated DC-SIGN THP-1
cells with purified HIV-1 gp120, CMV gB, HSV-1 gB, VZV
gB, HSV-1 gD, or VZV gE. Following exposure to each
single envelope glycoprotein, cells were incubated with
biotinylated HIV-1 gp120, the binding of which to DC-
SIGN THP-1 cells was evidenced by immunostaining
and FACS analysis. Among the herpesvirus proteins as-
sessed, only CMV gB decreased the binding of biotinyl-
ated HIV-1 gp120 on DC-SIGN. This competitive effect
of CMV gB was almost as efficient as that shown by
unlabeled HIV-1 gp120, mannan, or anti-DC-SIGN mAb
1B10 (Figure 7B). Pretreatment of DC-SIGNTHP-1 cells
and MD-DC with recombinant CMV gB before incuba-
tion with CMV virions also efficiently blocked transmis-
sion of CMV to susceptible MRC-5 cells (data not
shown).
To investigate whether DC-SIGNR could also bind
to CMV gB, we incubated HEK 293T cells transiently
transfected with cDNA encoding DC-SIGN or DC-SIGNR
in the presence of biotinylated-HIV-1 gp120, -CMV gB,
or -BSA (Figure 7C). No binding was observed when
incubating transfected cells with the control BSA. In
contrast, both HIV-1 gp120 and CMV gB efficiently
bound to HEK 293T cells expressing either DC-SIGN or
DC-SIGNR. Both interactions were calcium dependent
since they were blocked by EGTA (data not shown).
Surprisingly, at low concentrations CMV gB displayed a
higher apparent affinity than HIV-1 gp120 for DC-SIGNR,
whereas both viral glycoproteins bound to DC-SIGN-
expressing cells with comparable efficiency. Together,
these results demonstrated that CMV gB is a CMV ligand
for DC-SIGN and DC-SIGNR. It deserves to be investi-
gated whether this capacity is restricted to CMV gB or
is shared by other CMV envelope glycoproteins.
Characterization of DC-SIGN-Glycoprotein Interactions
The surface plasmon resonance (SPR) technology was
used to further analyze the characteristics of DC-SIGN
binding to HIV-1 gp120 and CMV gB in vitro. Typical
sensorgrams were obtained by injection of a concentra-
Figure 5. Requirement of DC-SIGN Cytoplasmic Domain for CMV tion range of recombinant soluble CRD domain of DC-
Transmission SIGN (0.13 to 1 M) over surfaces functionalized with
(A) Cell surface expression of wt or mutated DC-SIGN (35 and HIV-1 gp120 (Figure 7D, left panel), CMV gB (Figure
20) receptors analyzed by immunostaining (1B10 mAb) and flow
7D, middle panel), or HSV-1 gB (Figure 7D, right panel).cytometry.
Visual inspection of the binding curves immediately(B) CMV binding capacity of THP-1 expressing wt or truncated DC-
showed that DC-SIGN binds to HIV-1 gp120 and CMVSIGN revealed by anti-CMV gB mAb.
(C) Parental or DC-SIGN cells were incubated, either at 4C or at gB, while only displaying negligible binding to HSV-1
37C for 2 hr, with ADGFP CMV (moi  0.1) and cocultured with gB. Binding of DC-SIGN CRD to both HIV-1 gp120 and
MRC-5 cells for 3 days. Infection was assessed by estimating the CMV gB was strongly inhibited by the anti-DC-SIGN
number of GFP-expressing cells.
1B10 mAb and EDTA (data not shown). The binding
curves were then individually fitted to a Langmuir model
(A  B  AB). This analysis returned an average on rategB has been proposed to play central roles in virion
penetration into cells, transmission from cell to cell, and kon  3.33  103 M1S1, and off rate koff  1.01  103
S1, thus giving an equilibrium dissociation constant offusion of infected cells (Navarro et al., 1993).
Recombinant, biotinylated CMV gB was directly 0.30 M for HIV-1 gp120, and kon  4.4  103 M1S1,
koff  1.26 103 S1, leading to an equilibrium dissocia-bound and detected on DC-SIGN-expressing THP-1
cells or MD-DC, but not on parental THP-1 (Figure 7A), tion constant of 0.29 M for CMV gB. Since the affinities
that characterize the DC-SIGN CRD binding to HIV-1and similar findings were observed with unlabeled CMV
gB (data not shown). The attachment of CMV gB to cells gp120 and to CMV gB are similar, the higher binding
DC-SIGN Mediates CMV Infection
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Figure 6. DC-SIGN Expression Renders Susceptible Cells Permissive to CMV Infection
(A) Cells were pretreated for 30 min with medium (gray bars), anti-DC-SIGN 1B10 mAb (open bars), or an isotypic control mAb (dashed bars)
and thereafter incubated with ADGFP strain (1 PFU/cell). HEK 293T were transiently transfected either with a DC-SIGN cDNA plasmid or a
control plasmid (pcDNA3.1).
(B) HEK 293T cells were transiently transduced with DC-SIGN or DC-SIGNR cDNAs and incubated with ADGFP. In (A) and (B), GFP-expressing
cells were quantified by flow cytometry at 3 days after infection.
(C) THP-1, DC-SIGN THP-1 cells, or MD-DC were pretreated as described in (A) (same symbols) and infected with TB40/E CMV (moi  1)
for 3 days. CMV infection was assessed by immunostaining with specific CMV IEA/EA mAb. Total number of CMV IEA/EA-positive cells on
the slide was determined by extrapolating the number of positive cells contained in the optical field of the microscope (10 objective).
(D) MD-DC, MRC-5, parental, and DC-SIGN THP-1 cells were pretreated and infected as described in (C). Noninternalized viral particles were
removed by short incubation in a low pH buffer. At day 14 after infection, virions released in culture supernatants were titrated on MRC-5
cells by plaque assays. Numbers on top of histograms indicate the rate of viral amplification. These values were calculated by dividing the
absolute number of CMV particles collected in supernatants by the absolute number of CMV particles used to infect cells (20,000 PFU).
level observed with the HIV-1 gp120 activated surface ing recombinant soluble forms of DC-SIGN CRD, which
compared to the CMV gB surface (Figure 7D, left and are monomers (our unpublished data). The affinity of
middle panels) may simply reflect a difference in immo- CMV gB for DC-SIGN measured by SPR was 0.3 M
bilization or in glycan density between both proteins. and was comparable to that estimated for HIV-1 gp120
(Mitchell et al., 2001). This relatively low affinity is likely
due to the inability of CRD to multimerize. The estimatedDiscussion
affinity (Kd) of HIV-1 gp120 for the natural DC-SIGN
molecule is 1.4 nM (versus 5 nM for CD4) (Curtis et al.,In the present report, we provide insights into the mech-
1992). These findings suggest that like HIV-1 gp120,anisms of interaction of CMV with DC and the transmis-
CMV gB would display high affinity for oligomerizedsion of CMV infection to other cell targets. We show
DC-SIGN.that DC-SIGN accounts for most of the binding of CMV
DC-SIGN-bound CMV retains infectious capacityto DC and mediates the attachment of CMV virions when
since, upon binding onto DC-SIGN THP-1 cells or MD-expressed in DC-SIGN negative cells. Interaction of
DC, CMV is transmitted to permissive cells where theCMV with DC-SIGN occurs through specific binding with
virus replicates actively. DC are receptive to CMV infec-at least one CMV envelope glycoprotein, CMV gB. DC-
tion by primary, nonadapted CMV isolates and refractorySIGN is a type II membrane protein in which the extracel-
to infection by adapted, CMV laboratory strains. Takinglular domain encompasses the CRD and a stalk that
advantage of this characteristic, we show that the ca-mediates tetramerization (Mitchell et al., 2001). Like DC-
pacity of DC to transmit CMV to permissive cell targetsSIGN, CMV gB is also present in multimeric complexes
can be dissociated from the ability of CMV to infect andin CMV envelope (Scheffczik et al., 2001). CMV gB-DC-
SIGN interactions analyzed by SPR were conducted us- replicate in DC. This result was confirmed using DC-
Immunity
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Figure 7. Identification of the CMV gB as a Viral Ligand for DC-SIGN and Characterization of the DC-SIGN/CMV gB Interaction by SPR
(A) Binding of CMV gB to DC-SIGN. DC-SIGN THP-1 cells or MD-DC were pretreated with medium (black closed circles), anti-DC-SIGN 1B10
mAb (open circles), or an isotypic, control mAb (gray closed circles) and thereafter incubated with biotinylated CMV gB. Cell-bound CMV gB
was revealed by PE-labeled streptavidin. Incubation of parental THP-1 cells with biotinylated CMV gB is also shown (black closed triangles).
(B) Competition assay of biotinylated HIV-1 gp120 binding to DC-SIGN. Parental (upper panel) or DC-SIGN THP-1 cells (all other panels)
were incubated with 2 g/ml of biotinylated HIV-1 gp120. DC-SIGN THP-1 cells were left untreated or preincubated with potential competitors
(unlabeled HIV-1 gp120, mannan, anti-DC-SIGN 1B10 mAb, control isotypic mAb, or envelope glycoproteins from CMV gB, HSV-1 gB, and
gD or VZV gE and gB) before incubation with biotinylated HIV-1 gp120. MFI of biotinylated HIV-1 gp120 staining is indicated in the upper-
right corner of histograms. In each panel, control staining (dotted line) and biotinylated HIV-1 gp120 labeling in the absence of competitor
(gray filled profile) or after preincubation with competitors (black filled histogram) are shown.
(C) Binding of CMV gB to DC-SIGNR. HEK 293T cells were transiently transfected either with a control plasmid or plasmids encoding DC-
SIGN or DC-SIGNR cDNAs. Transfected cells were incubated with increasing concentrations of biotinylated-CMV gB (dashed bars), biotinylated-
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SIGN HeLa cells which were capable of transmitting attachment of CMV on cell membranes as well as for
its entry into cells, is postulated (Boyle and Compton,CMV to permissive target cells, while CMV IE antigen
expression was never detected in these refractory cells. 1998). Annexin II, which binds to CMV gB (Pietropaolo
and Compton, 1997) and a 92.5 kDa protein which bindsThis DC-SIGN function is reminiscent of the aptitude for
transmission of infection to CD4 T lymphocytes shown to CMV gH (Baldwin et al., 2000) have been proposed
to play this role. It is unlikely that DC-SIGN is the elusiveeither by HIV-1-pulsed-DC or -DC-SIGN-transduced
cells. CMV receptor that ultimately determines entry of the
enveloped virions and replication in CMV infection-sus-Binding to and transfer of HIV-1 from DC-SIGN cells
appear to be separable steps (Pohlmann et al., 2001a). ceptible cells. Indeed, CMV entry and infection occur in
a number of cell types (i.e., MRC-5 fibroblasts and U373Recently, it has been shown that efficient transmission
of HIV to CD4 T lymphocytes from DC-SIGN-express- MG astrocytoma cells) where DC-SIGN is not expressed.
The putative CMV receptor in these cells might be differ-ing THP-1 cells requires internalization signals encoded
in the cytoplasmic domain of the lectin (Kwon et al., ent from a lectin, although the existence of yet unidenti-
fied DC-SIGN-like molecules accounting for binding and2002). The requirement of DC-SIGN cytoplasmic signals
for efficient trans-infection (named trans-enhancement) entry of CMV cannot be formally ruled out.
The capacity of DC-SIGN to promote in cis CMV repli-becomes particularly evident when low amount of virus
are used as inoculum (Geijtenbeek et al., 2000b). Simi- cation in otherwise low-susceptible cells can be ex-
plained by three not mutually exclusive hypotheses. DC-larly to HIV, suboptimal inoculums of CMV become
highly infectious when transferred from DC-SIGN SIGN owns the capacity to capture and internalize HIV-1
in DC (Kwon et al., 2002). By analogy, DC-SIGN mightTHP-1 cells. Moreover, DC-SIGN derivatives 35 or 20
failed to support CMV transmission to highly susceptible promote internalization and trafficking of CMV to an
intracellular compartment where it could initiate the in-cells, and incubation of CMV with wild-type- or trun-
cated-DC-SIGN-expressing cells at 4C prevented CMV fectious cycle. Alternatively, attachment of CMV to DC-
SIGN, or DC-SIGNR, might facilitate the interaction withtransmission to permissive cells. These findings suggest
that endocytosis of the receptor is required for efficient the authentic cellular receptor, which ultimately would
account for CMV entry. Such a function would be remi-transmission of CMV to permissive cells. However, our
experiments do not permit ruling out the involvement niscent of the facilitating effect shown by DC-SIGN on
HIV infection of T lymphocytes displaying low levels ofof putative transduction of intracellular signals in this
phenomenon since deletion of DC-SIGN cytoplasmic CCR5 (Lee et al., 2001). Finally, differentiation of THP-1
cells with TPA was shown to induce permissiveness todomains or inhibition of cell signal activation at 4C may
preclude DC-SIGN-dependent cell activation. Overall, CMV replication (Weinshenker et al., 1988). Similarly,
signal transduction through DC-SIGN could lead to cel-these findings suggest that in the natural CMV infection,
DC-SIGN promotes take up of CMV and permits en- lular differentiation and subsequent CMV replication.
Regarding CMV infection, the in cis capacity of DC-hancement of CMV transmission by interstitial DC to
other cells. The hypothesis of in vivo CMV transport by SIGN to facilitate viral entry is likely of biological rele-
vance since the blockade by specific anti-DC-SIGNDC raised the question of the stability of DC-
SIGN-bound CMV particles. As previously described for antibodies drastically reduces infectiveness of DC by
primary, CMV isolates. The capacity of DC to supportHIV, we evidenced that DC-SIGNTHP-1 cells can trans-
mit CMV to other cell targets after 5 days in culture CMV infection may be related to the amount of DC-SIGN
expressed at their surface. Thus, immature DC whichwhereas cell-free virus lose infectivity upon incubation
at 37C for 24 to 48 hr. The ability of DC to transmit express high levels of DC-SIGN can be infected by CMV
(Raftery et al., 2001; Riegler et al., 2000), while maturedinfection for a long time after exposure supports the
hypothesis that DC transport small amounts of CMV DC that display low DC-SIGN expression show reduced
susceptibility to CMV (our unpublished data). Expres-from entry sites to target organs where they could trans-
mit infectious CMV particles by cell-to-cell contact. sion of DC-SIGN on immature DC of intestinal and geni-
tal mucosae (Geijtenbeek et al., 2000b; Jameson et al.,A striking feature of DC-SIGN-CMV interactions is the
capacity of the lectin to facilitate the infection of low- 2002) may confer to this cofactor a crucial role for the
infection of these primary target cells at the anatomicalsusceptible cells by CMV. Thus, THP-1 cells that do not
normally support CMV replication become productively sites where initial CMV transmission or propagation
most probably take place. A recent study described ainfected as they express DC-SIGN. CMV attachment to
host cells is supposed to occur namely through low- monocyte-derived macrophage circulating subset, ex-
pressing DC markers in vivo (Soderberg-Naucler et al.,affinity interactions with heparan sulfate proteoglycans
(Compton et al., 1993; Kari and Gehrz, 1992). However, 1997). This subset was shown to harbor latent CMV
which reactivates upon allogeneic stimulation. It ap-beyond this primary site of binding, the existence of
an alternative cellular cofactor, required for a strong pears necessary to investigate the expression of DC-
HIV-1 gp120 (black bars), or biotinylated-BSA (open bars). Binding of biotinylated proteins was revealed by PE-conjugated streptavidin and
analyzed by flow cytometry. Values are represented as MFI.
(D) SPR analysis of DC-SIGN/CMV gB interaction. The recombinant soluble CRD of DC-SIGN at (from bottom to top) 0.13, 0.21, 0.36, 0.6, or
1 M was injected over surfaces coated with HIV-1 gp120 (left panel), CMV gB (middle panel), or HSV-1 gB (right panel) to analyze the
association phase, after which running, buffer alone was injected to analyze the dissociation phase. Binding responses (response unit, RU)
are reported as a function of time. Dissociation constants (Kd) are indicated for left and middle panels.
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isolate) was obtained from the NIBSC repository (Medical ResearchSIGN by these cells which could represent a biological
Council, United Kingdom). VZV gB and VZV gE (Jacquet et al., 1995)link between this newly identified dendritic-like subset
were gifts from Dr. A. Jacquet (Department of Applied Genetics,and the results we provide in this report. As recently
Gosselies, Belgium). HSV-1 gB and HSV-1 gD (Sisk et al., 1994) were
reported, CMV-infected DC display decreased antigen provided by Dr. G.H. Cohen (University of Pennsylvania, Philadel-
presentation and differentiation capacities (Andrews et phia). Expression and purification of CMV gB (gift of Dr. Claude
Meric, Aventis Pasteur, Marcy l’Etoile, France) were previously de-al., 2001; Raftery et al., 2001). Hence, by promoting DC-
scribed (Norais et al., 1996; Pass et al., 1999). Anti-CMV gB (clonemediated trans-infection of target cells as well as cis-
1-M-12, IgG1) and anti-DC-SIGNR (clone 120604, IgG2a) mAbs wereinfection of DC, DC-SIGN could be involved, apart from
purchased from Biodesign International (Saco, ME) and R&D Sys-virus propagation, in CMV-mediated altered immune re-
tems (Minneapolis, MN), respectively. Anti-LIF 7D2 (Taupin et al.,
sponse. 1993) and anti-SDF-1 K15C monoclonal antibodies (mAb) (Amara
We show that DC-SIGNR is also able to bind CMV gB et al., 1999) were used as isotypic controls.
and to promote cis-infection of apparently low-suscepti-
Cellsble cells. This DC-SIGN homolog is mainly expressed
MRC-5 (Bio Me´rieux S.A., Marcy l’Etoile, France) and U373 MGon EC (Bashirova et al., 2001; Pohlmann et al., 2001b)
(ECCC, Salisbury, United Kingdom) are CMV-, HSV-1- and VZV-which are known to be preferential targets of CMV in
permissive cell lines, from fibroblastic and astrocytic origin, respec-
vivo and replicate primary, nonadapted CMV strains in tively. Parental and DC-SIGN THP-1 cells (wild-type and 35 and
vitro (Kahl et al., 2000). The expression of DC-SIGNR on 20 mutants lacking the first 35 and 20 amino acids of the cyto-
plasmic domain, respectively) (Kwon et al., 2002) were a gift fromplacental EC and macrophages (Soilleux et al., 2001)
Dr. D.R. Littmann (Skirball Institute of Biomolecular Medicine, Newcould be involved in the materno-fetal transmission of
York). DC-SIGN HeLa cells were generated by infecting HeLa cellsCMV during congenital infections. Similarly, DC-SIGNR
with an HIV-derived vector (TRIP-U3 vector, a gift from Dr. P.expressed in liver EC may be implicated in CMV-induced
Charneau, Institut Pasteur, Paris) encoding a human DC-SIGN
hepatitis, one of the most frequent clinical forms of this cDNA. MD-DC were generated from peripheral blood monocytes
infection. treated with 20 ng/ml IL-4 (Schering-Plough, Kenilworth, NJ) and
100 ng/ml GM-CSF (Leucomax, Novartis-Pharma, Rueil Malmaison,Murine CMV shares many essential characteristics
France) (Romani et al., 1994). At day 5, virtually the totality of cellswith its human counterpart and has been a widely stud-
displayed the phenotype CD1a, HLA-DR, CD80low, CD86low,ied model for CMV infection. It has been shown that
CD83, CD14 characteristic of immature MD-DC.infection of DC by murine CMV prevents delivery of the
signals required for T cell activation. The impairment of DC-SIGN cDNA and anti-DC-SIGN Antibodies
DC functions by murine CMV is supposed to be detri- DC-SIGN cDNA was isolated from human immature MD-DC by RT-
PCR. For expression in mammalian cells, human DC-SIGN was sub-mental for the host immune responses (Andrews et al.,
cloned at the EcoRI/XbaI sites of the pcDNA3 myc-His (version A)2001). The cloning of several homologs of DC-SIGN in
plasmid (Invitrogen, Carlsbad, CA). The DC-SIGNR cDNA was a giftmice (Park et al., 2001) should provide this model with
from Dr. R.W. Doms (University of Pennsylvania, Philadelphia). Anti-an invaluable tool for studying the implication of DC-
DC-SIGN clone 1B10 (IgG2a) was obtained by immunizing BALB/c
SIGN-like molecules in the dynamic of CMV dissemina- mice with HEK 293T cells transfected with DC-SIGN cDNA, screened
tion, the role of the different subsets of DC in the course by indirect immunofluorescent staining and FACS analysis on DC-
SIGN HeLa cells and used as purified immunoglobulins.of CMV propagation, and eventually the causes of CMV-
induced immunosuppression.
Infection AssaysWe hope that our findings will contribute to the defini-
For trans-infection experiments, cells were incubated with viral sus-tion of future strategies for prophylaxis of CMV infection.
pensions (CMV, VZV, or HSV-1, moi 1) for 2 hr at 37C. Thereafter,
Thus, it could be envisaged that in vivo inhibition of unbound viral particles were removed by extensive washes and
CMV/DC-SIGN or DC-SIGNR interaction might result in cells were cocultured with subconfluent MRC-5 or U373 MG cell
monolayers. After 24 to 72 hr, infected MRC-5 or U373-MG cellsreduced virus dissemination in the host organism
were fixed, permeabilized, and stained with specific mAbs directedthrough inhibition of DC-mediated trans-infection of in
against IEA- or EA-CMV (mAbs E13 and 2A2, respectively), VZVvivo susceptible cells and/or infection of DC-SIGN- or
(mAb 2013), or HSV (mAb CHA-437) (Argen Biosoft, Varilhes, France).
DC-SIGNR-expressing cells, namely EC or DC. Pre- When indicated, MD-DC or THP-1 (parental or DC-SIGN) cells were
venting DC infection should in turn protect antiviral im- incubated with EGTA (5 mM), mannan, or anti-DC-SIGN (1B10 mAb)
mune response by blocking the suppressive effect of for 30 min at 4C prior to challenge with infectious preparations.
Infection by ADGFP strain was assessed by counting GFP-express-CMV on these cells.
ing cells at day 3 by flow cytometry. For long-term infectivity experi-
ments, DC-SIGN or parental THP-1 cells were incubated with
Experimental Procedures
ADGFP (moi  1) for 4 hr at 37C. After extensive washes, infected
cells were incubated at 37C, and an aliquot of these cells was
Herpesviruses
added to a subconfluent MRC-5 cell culture every 2 days during
AD169, Towne (CMV laboratory strains), and TB40/E (CMV clinical the assay.
isolate) were provided by Dr. S. Michelson (Institut Pasteur, Paris) To assess the effect in cis of DC-SIGN during infection, cells
and Dr. C. Sinzger (Tubingen, Germany), respectively. ADGFP is a were incubated with low titers of CMV (moi  0.1) for 2 hr at 37C.
genetically modified AD169 strain encoding an Enhanced Green Noninternalized viral particles were removed by washes in low pH
Fluorescent Protein driven by the CMV immediate-early gene pro- citrate buffer (pH 3). The number of infected cells was determined
moter (Borst et al., 2001). VZV and HSV-1 clinical isolates were by immunocytochemistry 72 hr after infection. Supernatants from
obtained from Dr. Isabelle Garrigue (Laboratory of Virology, CHU infected cells kept in culture for 14 days were harvested to quantify
Pellegrin, Bordeaux, France). de novo generated virions by plaque-assay titration.
Reagents, Antibodies, and Viral Glycoproteins HIV-1 gp120 Binding Competition and CMV gB Direct
Mannan and EGTA were purchased from Sigma-Aldrich Corporation Binding Assays
(Saint Louis, MO). Soluble viral envelope glycoproteins were pro- DC-SIGN THP-1 cells were washed two times, resuspended in ice-
cold binding buffer (1 mM CaCl2, 2 mM MgCl2, and 0,1% Bovineduced and purified from mammalian or insect cells. HIV-1 gp120 (MN
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Serum Albumin in PBS) at 106 cells/ml and pretreated or not for 15 Banchereau, J., and Steinman, R.M. (1998). Dendritic cells and the
control of immunity. Nature 392, 245–252.min with competitors (20 g/ml). Thereafter, recombinant biotinyl-
ated CXCR4-tropic (MN isolate) HIV-1 gp120 (2 g/ml; Immunodiag- Bashirova, A.A., Geijtenbeek, T.B., van Duijnhoven, G.C., van Vliet,
nostics Inc., Woburn, MA) was added for 30 min at 4C. After exten- S.J., Eilering, J.B., Martin, M.P., Wu, L., Martin, T.D., Viebig, N.,
sive washing, cell-bound biotinylated HIV-1 gp120 was revealed by Knolle, P.A., et al. (2001). A dendritic cell-specific intercellular adhe-
flow cytometry using FITC-conjugated Streptavidin (Immunotech sion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is
SA, Marseille, France). For CMV gB binding experiments, recombi- highly expressed on human liver sinusoidal endothelial cells and
nant soluble CMV gB and Bovine Serum Albumine (BSA; Amersham promotes HIV-1 infection. J. Exp. Med. 193, 671–678.
Pharmacia Biotech, Uppsala, Sweden) were biotinylated with sulfo-
Bodaghi, B., Slobbe-van Drunen, M.E., Topilko, A., Perret, E., Vos-
NHS biotin, according to manufacturer instructions (Pierce, Rock-
sen, R.C., van Dam-Mieras, M.C., Zipeto, D., Virelizier, J.L., LeHoang,
ford, IL).
P., Bruggeman, C.A., and Michelson, S. (1999). Entry of human cyto-
megalovirus into retinal pigment epithelial and endothelial cells by
Analysis of DC-SIGN Interactions with Viral Envelope
endocytosis. Invest. Ophthalmol. Vis. Sci. 40, 2598–2607.
Glycoproteins by SPR
Borst, E.M., Mathys, S., Wagner, M., Muranyi, W., and Messerle, M.The cDNA coding for the DC-SIGN CRD (amino acids 254–404) was
(2001). Genetic evidence of an essential role for cytomegalovirusobtained by PCR and cloned into pET15b (Novagen). The protein
small capsid protein in viral growth. J. Virol. 75, 1450–1458.was expressed in Escherichia coli C41(DE3) as inclusion bodies.
Refolding of the protein has been done by dilution and dialysis as Boyle, K.A., and Compton, T. (1998). Receptor-binding properties
described (Mitchell et al., 2001). Purification of refolded DC-SIGN of a soluble form of human cytomegalovirus glycoprotein B. J. Virol.
CRD has been achieved in two steps: first on a Ni-NTA (QIAGEN) 72, 1826–1833.
column equilibrated in 25 mM Tris Cl (pH 7.8), 150 mM NaCl, and Chou, S.W., and Dennison, K.M. (1991). Analysis of interstrain varia-
4 mM CaCl2 (loading buffer) and eluted with a linear gradient of tion in cytomegalovirus glycoprotein B sequences encoding neutral-
imidazole and second on a Mannose-agarose column equilibrated ization-related epitopes. J. Infect. Dis. 163, 1229–1234.
in loading buffer, and eluted in buffer where CaCl2 was replaced by Compton, T., Nepomuceno, R.R., and Nowlin, D.M. (1992). Human
EDTA (10 mM). Pooled fractions are then concentrated and dialyzed
cytomegalovirus penetrates host cells by pH-independent fusion at
against loading buffer.
the cell surface. Virology 191, 387–395.
Four flow cells of a Biacore B1 sensor chip were activated as
Compton, T., Nowlin, D.M., and Cooper, N.R. (1993). Initiation ofdescribed (Amara et al., 1999). The first flow cell was then blocked
human cytomegalovirus infection requires initial interaction with cellwith 50 l of 1 M ethanolamine (pH 8.5) and served as a control
surface heparan sulfate. Virology 193, 834–841.surface. The three other ones were treated with soluble gp120, gB
CMV, or gB HSV (concentration range 1–10 g/ml in 10 mM acetate Curtis, B.M., Scharnowske, S., and Watson, A.J. (1992). Sequence
buffer [pH 5]). Typically, this procedure permitted the coupling of and expression of a membrane-associated C-type lectin that exhib-
approximately 250–350 resonance units (RU) of proteins. For binding its CD4-independent binding of human immunodeficiency virus en-
assays, DC-SIGN CRD was diluted in loading buffer and was allowed velope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 89, 8356–
to react with the sensor chip (at 30 l/min). In a typical analysis, 8360.
DC-SIGN CRD (0.13 to 1 M, see legend to Figure 7D) was injected Einhorn, L., Gadler, H., and Wahren, B. (1982). Adsorption of purified
over the four flow cells for 8 min, after which the complexes were human cytomegalovirus and induction of early antigens in different
rinsed with buffer to analyze the dissociation phase. The surface cells. J. Med. Virol. 10, 225–234.
was then regenerated with a 6 min pulse of running buffer containing
Geijtenbeek, T.B., Krooshoop, D.J., Bleijs, D.A., van Vliet, S.J., van50 mM EDTA instead of CaCl2. Sets of sensorgrams were analyzed Duijnhoven, G.C., Grabovsky, V., Alon, R., Figdor, C.G., and vanusing the BIAevaluation 3 software.
Kooyk, Y. (2000a). DC-SIGN-ICAM-2 interaction mediates dendritic
cell trafficking. Nat. Immunol. 1, 353–357.Acknowledgments
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